FDA panel endorses booster shot for J&J COVID-19 vaccine
The FDA’s advisory panel recommends booster be offered at least two months after initial J&J shot U.S. health advisers endorsed a booster of Johnson & Johnson’s COVID-19 vaccine Friday, citing concern that Americans who got the single-dose shot aren’t as protected as those given two-dose brands. J&J told the Food and Drug Administration that an…